Catching up with returning ProQRian René Beukema Blog In this personal interview, we speak to ProQR’s Chief Corporate Development Officer & General Counsel, René Beukema on his return to ProQR. February 09, 2023
Today marks an expansion of the ProQR and Lilly partnership News update Today we are delighted to announce the further expansion of our collaboration with Lilly. Lilly is a leader in innovative RNA science, making them a great partner for our Axiomer technology. December 22, 2022
ProQR Analyst Event Webcast During this webcast ProQR leadership will highlight key advancements from its clinical-stage pipeline and Axiomer® RNA editing platform. November 18, 2021